New understanding of the molecular genetics of successful fertilization

NewsGuard 100/100 Score

A new paper in the February 15th issue of Genes & Development lends novel insight into the cellular changes that occur in sperm while they reside in the female reproductive tract - providing a new understanding of the molecular genetics of successful fertilization.

It had been believed for decades that spermatozoa are translationally silent. However, Dr. Yael Gur and Haim Breitbart (Bar-Ilan University, Israel) now show that, in fact, protein translation does take place in mammalian sperm prior to fertilization.

Their paper has been released online ahead of print at www.genesdev.org.

After ejaculation, sperm reside in the female reproductive tract for several hours. During this time, a number of biochemical changes take place within sperm, collectively known as "capacitation," that render the sperm competent to penetrate and fertilize the female oocyte.

In their new report, Drs. Gur and Breitbart demonstrate that human, rat, bovine and mouse sperm all incorporate labeled amino acids into polypeptides during the capacitation phase. They identify that mitochondrial translation machinery (as opposed to cytoplasmic) directs translation of nuclear-encoded genes in sperm, and that its inhibition leads to a marked decrease in sperm motility, actin polymerization, the acrosome reaction and in vitro fertilization rates.

Thus, protein translation in sperm is essential for sperm functions that directly contribute to fertilization. Dr. Breitbart is confident that "The new findings would give us better understanding for treatment of male infertility and developing new male or female contraceptives."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
ACMG releases new Points to Consider statement on the clinical utility of polygenic risk scores for embryo selection